Corcept Therapeutics | Umsatzkosten



Cost Of Sales Veränderung Datum
Acadia Pharmaceuticals USD 20.73M 342K 2025-06
Alaunos Therapeutics 0 18K 2024-09
ANI Pharmaceuticals USD 97.9M 24.86M 2025-06
Ardelyx USD 18.26M 2.54M 2024-12
Aurora Cannabis CAD 78.85M 891K 2024-12
BioMarin Pharmaceutical USD 154.94M 3.38M 2025-06
Bristol-Myers Squibb USD 3.37B 339M 2025-06
Canopy Growth CAD 50.66M 9.51M 2024-12
Corcept Therapeutics USD 3.43M 1.03M 2025-06
Eli Lilly USD 2.45B 223.6M 2025-06
J&J USD 7.6B 304M 2025-06
Knight Therapeutics CAD 47.25M 990K 2024-09
Merck USD 2.82B 53M 2025-06
Novartis USD 3.32B 95M 2025-06
Novartis USD 3.31B 73M 2024-12
Pacira USD 55.19M 20.88M 2025-06
Pfizer USD 4.99B 2.4B 2025-06
Supernus Pharmaceuticals USD 37.65M 21.88M 2025-06
TG Therapeutics USD 18.94M 3.4M 2025-06


Corcept Therapeutics Umsatzkosten - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Aug 2025.